1. Effect of CDT6 on factors of angiogenic balance in tumour cell lines.
- Author
-
Bouïs DR, Dam WA, Meijer C, Mulder NH, and Hospers GA
- Subjects
- Angiogenic Proteins genetics, Animals, Cell Line, Tumor, Endostatins biosynthesis, Endostatins metabolism, Gene Expression, HeLa Cells, Humans, Melanoma blood supply, Melanoma genetics, Melanoma metabolism, Neoplasms genetics, Neovascularization, Pathologic genetics, Neovascularization, Pathologic metabolism, Reverse Transcriptase Polymerase Chain Reaction, Tissue Inhibitor of Metalloproteinase-1 metabolism, Transfection, Vascular Endothelial Growth Factor A biosynthesis, Vascular Endothelial Growth Factor A metabolism, Angiogenic Proteins biosynthesis, Neoplasms blood supply, Neoplasms metabolism
- Abstract
Background: Cornea-derived transcript 6 (CDT6, also known as AngX) is an angiopoietin-related factor resulting in anti-tumour effect in vivo. However, a recent abstract reported that CDT6 can also induce angiogenesis and promotes tumour growth. In our previous work, CDT6 had failed to show pro- or anti-angiogenic effects. It is unknown if CDT6 expression occurs in human cancer., Materials and Methods: An array of human tumour cell lines and tumour tissues was tested for CDT6-gene expression using RT-PCR. To address the controversial role of CDT6 on angiogenesis in different tumour models, the expression levels of four factors of the angiogenic balance (VEGF, endostatin, TIMP-1 and PAI-1) were determined in CDT6-transfected and control cells of the human and murine melanoma cell lines BLM and B16-F10. Endostatin was significantly up-regulated by CDT6 expression in the human model and significantly down-regulated in the mouse model. None of 18 cell lines or 23 tumours expressed CDT6., Conclusion: This contradictory effect on endostatin expression in human and mouse models may be an explanation for the conflicting results for the effect of CDT6 expression on angiogenesis.
- Published
- 2007